Add Company
Join Now

MediciNova Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MediciNova's estimated annual revenue is currently $2.8M per year.(i)
  • MediciNova's estimated revenue per employee is $155,000

Employee Data

  • MediciNova has 18 Employees.(i)
  • MediciNova grew their employee count by -14% last year.

MediciNova's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is MediciNova?

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MediciNova News

2022-04-17 - MediciNova Announces Publication of MN-166 (ibudilast ...

LA JOLLA, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the...

2022-04-17 - MediciNova Announces Publication of MN-166 (ibudilast ...

MediciNova Announces Publication of MN-166 (ibudilast) Data regarding Prevention of Metastasis in Uveal Melanoma in Molecular Cancer Research.

2022-04-13 - MediciNova Announces Completion of Enrollment in the ...

MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M18-33%N/A
#2
$2.4M18-28%N/A
#3
$2.7M18-14%N/A
#4
$2.2M18N/AN/A
#5
$1.6M18N/AN/A